Publications by authors named "Shohini Ghosh"

Claim this Profile
T
TRC150094, a Novel Mitochondrial Modulator, Reduces Cardio-Metabolic Risk as an Add-On Treatment: a Phase-2, 24-Week, Multi-Center, Randomized, Double-Blind, Clinical Trial.
Deepa Joshi, Prashant Gj, Shohini Ghosh, Anookh Mohanan, Shashank Joshi

Diabetes Metab Syndr Obesยท February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis